Issue 5: Pharma Digest
Welcome to your bi-weekly newsletter.?
The industry has never been more primed to drive positive change, however, post-Covid health systems are at their limit, so pharma must again evolve to take the lead. Keeping your organisation up to speed can be tricky - we're here to help solve that problem.?
The Digest is for you, the valued members of our Pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.?
Let's get started.?
PED: Turning the patient voice into a dataset?
Patients and pharma are teaming up to capture valuable patient experience data and they are only getting started. Find out the perspective of a patient researcher at Uppsala University, Novartis and Ipsen on working to co-create programs in our latest article here.?
Where do you see the majority of current pharma investment happening, among these areas of sustainability??
Where do you feel pharma is investing the most when it comes to ESG? Funding climate initiatives, reducing the company's carbon footprint, championing social initiatives such as the UN's healthcare for all, or on achieving diversity and inclusion within the company? Vote here.?
This Week's Top 5 Pharma News to Watch?
1. US appeals court preserves limited access to abortion pill (Reuters.com, April 13)?
2. FDA, citing safety concerns, places partial hold on Merck KGaA’s MS drug (Biopharma Dive, April 12)?
3. In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog (Fierce Pharma, April 10)?
4. Institute of Cancer Research embraces olaparib recommendation (Pharma Times, April 11)?
5. Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group (Reuters.com, April 12)?
领英推荐
Reuters Events: Pharma 2023 is the place where patient experts and pharma changemakers – from commercial, marketing, medical affairs, patient engagement, market access, RWE and Digital Health – share new best-practice, lessons learned and strategies for the future.?#REpharma2023?
Vendor basic passes SOLD OUT! Only one week left to register. Secure your pass for Pharma 2023 now!?
That rounds off Issue 5 of the Pharma Digest.?
We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next bi-weekly digest.??
As always, the Pharma team are on hand to answer your questions. You can connect with us on LinkedIn.?
EU Team?
Daniel Baker – Marketing/ Commercial?
Joey Buchholz – Medical Affairs?
Usmaan Khan – Patient?
Charlotte Bastiaanse – RWE/ Market Access?
?
USA Team?
Kana Hutton – Marketing/ Commercial?
Hannah Brady – Medical Affairs?
Daisy Beale – Patient/ Celle and Gene?
Charlotte Bastiaanse – RWE/ Market Access?
See you next time!?
?